查找临床试验
已按「流感」检索，对应国际通用词 influenza
共找到 20 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步正在招募不适用中国有中心NCT06446232
Influenza Vaccine Effectiveness in Among Young Children in Taiwan
Taiwan
年龄 6 Months – 18 Years
National Taiwan University Hospital
正在招募不适用中国有中心NCT07259252
Influenza Vaccination After Acute Coronary Syndrome
China
年龄 18 Years – 80 Years
Tongji Hospital
正在招募III 期中国有中心NCT07229547
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
China
年龄 12 Years – 17 Years
Ruijin Hospital
正在招募不适用中国有中心NCT06155188
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
China
年龄 1 Month – 18 Years
Nanfang Hospital, Southern Medical University
正在招募不适用中国有中心NCT06676644
Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines
Taiwan
年龄 65 Years – 不限
National Taiwan University Hospital
正在招募不适用中国有中心NCT06111612
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
China
年龄 18 Years – 55 Years
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
正在招募不适用中国有中心NCT06667063
Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection
China
年龄 18 Years – 不限
Zhongnan Hospital
正在招募不适用中国有中心NCT06946602
Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.
China
年龄 55 Years – 不限
Peking University People's Hospital
正在招募III 期中国有中心NCT03900988
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Hong Kong
年龄 18 Years – 不限
Chinese University of Hong Kong
正在招募不适用中国有中心NCT07846423
Abbott ID NOW Point-of-Care Testing
Taiwan
年龄 20 Years – 不限
China Medical University Hospital
正在招募III 期中国有中心NCT06573008
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
China
年龄 12 Years – 不限
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
正在招募III 期中国有中心NCT07827599
A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants
China
年龄 5 Years – 不限
Hoffmann-La Roche